Prostate specific antigen (PSA) is a widely used marker of diagnosis and prognosis in PCa, however there is evidence that changes in its levels are not related to survival outcomes (2) and PSA is often used mainly because of the lack of useful predictive markers (3). Here, KLK3 is linked to posterior cortical atrophy.